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ABSTRACT А number of ribosomal proteins in Escherichia coli undergo posttranslational modifications. Six ri-
bosomal proteins are methylated (S11, L3, L11, L7/L12, L16, and L33), three proteins are acetylated (S5, S18, and 
L7), and protein S12 is methylthiolated. Extra amino acid residues are added to protein S6. С-terminal amino 
acid residues are partially removed from  protein L31. The functional significance of these modifications has 
remained unclear. These modifications are not vital to the cells, and it is likely that they have regulatory func-
tions. This paper reviews all the known posttranslational modifications of ribosomal proteins in Escherichia coli. 
Certain enzymes responsible for the modifications and mechanisms of enzymatic reactions are also discussed.
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ABBREVIATIONS RNA – ribonucleic acid; rRNA – ribosomal RNA; mRNA – messenger RNA; tRNA – transfer 
RNA; IF2 – initiation factor 2; EF-Tu – elongation factor Tu; EF-G – elongation factor G; RF3 – release factor 3; 
GTP – guanosine-5′-triphosphate
INTRODUCTION
Ribosome is a sophisticated molecular machine that is 
responsible for the correct translation of genetic in-
formation from the mRNA nucleotide sequence into 
the amino acid sequence of the synthesized protein. A 
ribosome is a complex of ribosomal RNAs (rRNAs) and 
proteins consisting of two unequal parts (the large and 
the small subunits). The small subunit of Escherichia 
coli ribosomes consists of 16S rRNAs and 22 proteins 
(denoted as S1–S22); the large subunit consists of 5S 
and 23S rRNAs and 34 different proteins (L1–L36). 
Both rRNAs and ribosomal proteins undergo enzy-
matic modification in the cell. The N-terminal methio-
nine residue is cleaved in more than half of ribosomal 
proteins. Six proteins are methylated (S11, L3, L11, 
L7/L12, L16, and L33), three proteins are acetylated 
(S5, S18, and L7), the S12 protein is methylthiolated, 
additional amino acid residues are added to the S6 
protein, and the L31 protein undergoes partial prote-
olysis (L31) (Table 1). The nature of certain modifica-
tions of the ribosomal proteins of E. coli has yet to be 
determined [1].
Most genes encoding the enzymes that perform post-
translational modification have been identified. None-
theless, the functional role of these modifications re-
mains poorly studied. The central role of the ribosome 
in the mechanism of realization of the genetic informa-
tion in the cell permits to assume that modified riboso-
mal proteins can be significant in a number of mecha-
nisms of the regulation of gene expression.
PROCESSING OF THE N-TERMINUS 
OF RIBOSOMAL PROTEINS
Removal of the N-terminal methionine residue by me-
thionine aminopeptidase (MAP) is the most common 
type of posttranslational modifications in proteins. The 
terminal methionine is cleaved in 37 E. coli ribosomal 
proteins out of 57 (Table 2).
This modification is most frequently found in pro-
teins in which the amino acid following methionine has 
the short side chain [2]. Large side chains impede the 
penetration of a protein into the active site of methio-
nine aminopeptidase. If the second residue in a protein 
molecule is alanine (21 case) or leucine, proline, or gly-
cine, the N-terminal residue is always cleaved. If the 
first residue is followed by lysine, isoleucine, glutamine, 
arginine, aspartic acid, tyrosine, glutamic acid, phe-
nylalanine, or valine, as it is observed in 20 ribosomal 
proteins, the N-terminal methionine residue is always 
retained in the protein molecule. When position 2 is oc-
cupied by serine, in four cases out of five, the methio-
nine residue is retained. It should be noted that methio-
nine residues are cleaved only from a certain portion of 
protein L33 molecules; some chains (no more than 25%) 
remain with the N-terminal methylated methionine. 
It is possible that this is associated with the competi-
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tion between N-terminal methylation and methionine 
cleaving [3].
PROCESSING OF THE C-TERMINUS OF PROTEIN L31 
The C-terminus amino acid sequence of the ribosomal 
protein L31 (...RFNK) determined chemically in [4] dif-
fers from the one predicted on the basis of the nucleo-
tide sequence of the gene of this protein (…RFNKR-
FNIPGSK). A conclusion was made that protein L31 
undergoes C-terminal processing (there may be a spe-
cific protease removing the RFNIPGSK fragment). 
These data were subsequently refuted; the primary 
structure of L31 was shown to agree with the genomic 
structure [5]. However, a mass spectrometry analy-
sis of ribosomal proteins detects two peaks for L31: at 
7871.1 Da, corresponding to the complete sequence of 
L31 predicted on the basis of the genomic sequence and 
that at 6971.1 Da, corresponding to the L31 fragment 
without the C-terminus region ...RFNIPGSK [1].  Pro-
tein L31 molecules are apparently only partially pro-
cessed.
L31 is a component of a bacterial ribosome that has 
not been studied adequately. L31 is known to form a 
ribonucleoproteid complex with the rRNA proteins L5, 
L18, L25, and 5S. It is located at the vertex of the cen-
tral protuberance in immediate proximity to the site of 
the subunit contact. It is probable that the posttrans-
lational modification serves the purpose of protein ac-
tivation or has a regulatory role. However, there is no 
data on the function of the site-specific proteolysis of 
L31 or on its possible mechanism.
It is of interest that the E. coli genome contains two 
genes of protein L31 with a similar, but not identical, 
sequence [6]. Protein L31 that is present in cells un-
der “regular” laboratory conditions in which culturing 
is performed contains the “zinc ribbon” motif. When 
there is a deficiency in zinc ions, the expression of an-
other variant of L31 without the “zinc ribbon” is acti-
vated by the transcriptional regulator Zur. This switch-
ing likely facilitates economy of zinc ions in the cell. A 
similar mechanism has been described for ribosomal 
protein L36 [7].
METHYLATION OF RIBOSOMAL PROTEINS
Methylation is one of the most common types of post-
translational protein modifications to which various 
prokaryotic and eukaryotic proteins are subjected. 
Methylation is performed by special enzymes (meth-
yltransferases), which use S-adenosylmethionine as a 
methyl group donor. Five classes of methyltransferases 
differing in structure and substrate specificity exist.
The methylation of ribosomal proteins usually occurs 
at the side amino group of lysine or arginine; methyla-
tion of N-terminal amino groups is also common. Six ri-
bosomal proteins are methylated in E. coli cells (Table 1) 
[8]. Methyltransferases that are specific to two proteins 
(L11 and L3) (PrmA and PrmB, respectively) have been 
identified; the genes encoding them have been found. 
Very little data exist about other modifications.
Certain methylated ribosomal proteins play a sig-
nificant role in the functioning of ribosome: L7/L12 and 
L11 interact with the translation factors, and L3 par-
ticipates in ribosome assembly. However, regardless of 
the fact that the functions of these ribosomal proteins 
have been studied appreciably well, the biological sig-
nificance of their methylation is yet to be satisfactorily 
elucidated. Mutations in the genes encoding the cor-
responding methyltransferases do not result in notice-
able phenotypical changes. The methylation apparently 
regulates the intra- and intermolecular interactions in 
Table 1. Modifications of E. coli ribosomal proteins
Protein Modification position Modification Modifying enzyme
S5 N-terminal amino group Acetylation RimJ
S6 C-terminus Insertion of additional glutaminic acid residues RimK
S11
N-terminal amino group Methylation, formation of the isopeptide bond Not determined
Formation of isoaspartate residue Not determined
S12 Asp88 Methylthiolation RimO
S18 N-terminal amino group Acetylation RimI
L3 Gln150 Methylation PrmB
L7/L12 Lys81 Methylation Not determined
L11 Ala1, Lys3, Lys39 Methylation PrmA
L12 N-terminal amino group Acetylation RimL
L16 N-terminal amino group Methylation Not determined
L31 C-terminus Removal of amino acid residues Not determined
L33 N-terminal amino group Methylation Not determined24 | ACTA NATURAE |  VOL. 3  № 2 (9)  2011
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a protein or impacts its affinity to RNA, thus influenc-
ing various cell processes: translation regulation, its ac-
curacy, RNA processing, and ribosome assembly.
Protein L11 Methylation
Ribosomal protein L11 is the most strongly methyl-
ated protein of the bacterial translation apparatus [9]. 
It contains three methylated amino acid residues: the 
N-terminal alanine residue is trimethylated at the 
α-amino group, the 3rd and 39th lysine residues are 
trimethylated at ε-amino groups. Thus, a total of nine 
methyl groups are posttranslationally bound to the 
protein [10]. The methylation is performed by a single 
enzyme, PrmA (protein modification), which has been 
isolated and characterized [11]. It was ascertained that 
this protein has a mass of 31 kDa and uses S-adenosyl-
methionine as a methyl group donor and preferentially 
modifies the unbound protein L11. The latter fact at-
tests to the fact that methylation precedes the insertion 
of a protein into the ribosome [11].
The mutant E. coli strain containing no methyl 
groups in protein L11 was obtained. The position of the 
prmA gene encoding methyltransferase PrmA was de-
termined using this strain [12].
This enzyme has a unique substrate specificity, 
which enables the modification of several amino groups   
of the protein which belong to different amino acid res-
idues and are located at different sites with respect to 
the peptide backbone (α- and ε-amino groups). To do 
so, either the enzyme has to be bound to a substrate in 
several different orientations, or the system of flexible 
substrate positioning has to be used for the multiple 
modifications. This system facilitates the reorientation 
of the substrate with respect to the permanent bind-
ing site. The PrmA structure and the mechanism of its 
interaction with the substrate has been the subject of 
thorough study [13, 14]. 
Methyltransferase PrmA consists of two domains 
connected by a flexible linker (Fig. 1). A large cata-
lytic C-terminal domain is a typical example of class I 
methyltransferases. Seven-stranded β-sheet is flanked 
on both sides by α-helices. A small additional three-
stranded β-sheet acts as an interlink between the C-
terminal domain and the linker interdomain α-helix. 
The small N-terminal domain consists of a four-strand-
ed β-sheet flanked by an interdomain linker α-helix, 
on one side, and by an N-terminal α-helix, on the other 
side. The N-terminal domain PrmA is unique; it is ca-
pable of recognizing and binding protein L11 (Fig. 1) 
[13]. It was ascertained using bioinformatics methods 
that the structure of the N-terminal domain PrmA is 
reminiscent of the V-domain of the EF-G factor, which 
is located in close proximity to protein L11 upon bind-
ing with the ribosome [15].
Table 2. Posttranslational removal of the N-terminal me-
thionine residue in E. coli ribosomal proteins [1]
Protein Removal  
of Met
The second residue  
following Met
S1 ? Thr
S2 + Ala
S3 + Gly
S4 + Ala
S5 + Ala
S6 – Arg
S7 + Pro
S8 + Ser
S9 + Ala
S10 – Gln
S11 + Ala
S12 + Ala
S13 + Ala
S14 + Ala
S15 + Ser
S16 – Val
S17 + Thr
S18 + Ala
S19 + Pro
S20 + Ala
S21 + Pro
S22 – Lys
L1 + Ala
L2 + Ala
L3 – Ile
L4 – Glu
L5 + Ala
L6 + Ser
L7 + Ser
L9 – Gln
L10 + Ala
L11 + Ala
L12 + Ser
L13 – Lys
L14 – Ile
L15 – Arg
L16 – Leu
L17 – Arg
L18 – Asp
L19 – Ser
L20 + Ala
L21 – Tyr
L22 – Glu
L23 – Ile
L24 + Ala
L25 – Phe
L26 + Ala
L27 + Ala
L28 + Ser
L29 – Lys
L30 + Ala
L31 – Lys
L32 + Ala
L33 + Ala
L34 – Lys
L35 + Pro
L36 – LysREVIEWS
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The binding surface between the N-terminal do-
main PrmA and protein L11 is partially overlapped by 
the binding surface of L11 and 23S rRNA. Therefore, 
PrmA modifies L11 only in the unbound state, prior to 
its insertion into the ribosome. This fact is confirmed by 
the data obtained earlier on in vitro methylation [11]. 
The binding of the N-terminal domain PrmA to L11 is 
highly specific and is stabilized by a number of hydro-
gen bonds, whereas the catalytic C-terminal domain 
does not possess any specificity; its interaction with 
the substrate is stabilized only by the local hydropho-
bic interaction (the side chain of the modified lysine 
residue enters the active site via the tunnel formed by 
hydrophobic amino acid residues, which interact with 
the hydrophobic part of the side lysine radical). Due to 
the flexibility of the interdomain linker, the catalytic 
domain can change its position with respect to the N-
terminal domain bound to L11 and methylate all the 
amino groups that are available to it (Fig. 2).
In the structure of a catalytic domain, there is a spe-
cial hydrophobic pocket for the binding of S-adenosyl-
methionine; this pocket is open. This means that the 
exchange between S-adenosylhomocysteine (the re-
action product) and S-adenosylmethionine is possible 
without disturbance of the enzyme-substrate complex. 
The active site of PrmA contains no atoms that could 
impede the rotation of the methylated amino group, 
which allows the enzyme that are bound to the sub-
strate to trimethylate it. To methylate the amino group, 
it is necessary that the catalytic centre contain a basic 
amino acid residue that can accept a proton from the 
nitrogen atom. His104 located in the active site oppo-
site the cofactor binding site apparently acts as such a 
residue.
Thus, the methylation performed by enzyme PrmA 
is a rare example of simultaneous specific recognition 
of the target and multiple modifications of substrate 
due to the spatial separation of the binding site and 
the catalytic center, as well as their mutual mobility. 
A single methyltransferase molecule is capable of se-
quentially introducing nine methyl groups into protein 
L11, without the dissociation of the enzyme-substrate 
complex.
Protein L11 is a conservative component of the large 
subunit of the bacterial ribosome and is an active par-
ticipant of the interaction between the ribosome and 
the factors of translation initiation, elongation, and 
termination. It consists of two domains connected by 
a flexible linker: the C-terminal domain binding 23S 
rRNA and the N-terminal domain interacting with the 
translation factors [13]. The N-terminal domain is the 
target of antibiotic thiostrepton, which inhibits EF-G–
ribosome binding (resistance towards thiostrepton is 
ensured by a number of mutations in the N-terminal 
domain of protein L11) [16]. It was revealed via cryo-
electron microscopy that the N-terminal domain of L11 
is in direct contact with the EF-G [15] and EF-Tu fac-
tors [17].
All amino acid residues trimethylated with PrmA 
are located in the N-terminal domain. This arrange-
N-terminal 
domain
L11  
(N-terminal 
domain)
PrmA
C-terminal 
domain
Fig. 1. The PrmA–
L11 complex 
structure. PrmA 
and L11 are 
colored in salmon 
and cyan. The 
Lys39 side chain 
is shown in a stick 
representation 
[13].
N-terminal  
domain
C-terminal  
domain
SAM
Fig. 2. Superposition of four different conformations of 
PrmA. Apo-enzyme structures are colored in green and 
grey. The SAM-bound form of PrmA is colored in yellow. 
The structure of PrmA in the complex with L11 is colored in 
salmon [13].26 | ACTA NATURAE |  VOL. 3  № 2 (9)  2011
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ment of the modified residues near the site of contact 
with the translation factors may point to the functional 
significance of methylation. The PrmA structure is con-
servative in all bacteria, which may also attest to its 
contribution to L11 functions. Nevertheless, the func-
tion of modification carried out by PrmA has not, as 
yet, been ascertained. In addition to being viable, the 
strain with a mutation of the prmA gene does not differ 
noticeably from the wild-type strain (the same growth 
rate and the same behavior under stress conditions) [18, 
19]. This means that multiple methylation of L11 is not 
necessary for the normal functioning of the ribosome. 
Meanwhile, it may have an effect both on the rate and 
accuracy of such stages of ribosome functioning as de-
coding and translocation, which can be detected only 
using a very accurate kinetic in vitro analysis or by the 
in vivo introduction of specific mutations into protein 
L11 or other components of the translation apparatus 
[13].
Methylation of Protein L3
One methyl group is posttranslationally added to ribo-
somal protein L3 [20]. The methylation takes place at 
the amide group of the 150th glutamine residue [21]. 
Modification is performed by specific methyltrans-
ferase PrmB. Its gene has been identified [12]. PrmB 
is the first described methyltransferase with an amide 
nitrogen atom acting as its target.
The absence of methylation in protein L3 in the 
strain containing a mutation in the prmB gene is com-
bined with cold sensitivity. The growth rate of mu-
tant cells at 22°С is considerably lower than that in 
wild-type cells [22, 23]. This is due to the fact that at 
low temperatures ribosome assembly in mutant cells is 
inefficient; the structure and stability of the resulting 
intermediate ribonucleoproteid complexes differ from 
that of the corresponding intermediates in the wild-
type strain. Nevertheless, the mutant ribosomes that 
are completely formed at a reduced temperature do not 
differ from the wild-type ribosomes in terms of their 
stability. No difference in the translation rate or its ac-
curacy was observed neither in vivo nor in vitro [22].
In vitro studies of the activity of the PrmB enzyme 
demonstrated that protein L3, in the unbound state, 
does not undergo methylation. Neither does methyl-
transferase methylate, the completely assembled ribo-
some. The highest activity is observed in the partially 
assembled ribosome and in the presence of RNA (of any 
type, not necessarily ribosomal) in the reaction mixture 
[22].
Protein L3 is bound to the 3’-terminal site of 23S 
rRNA at the very first stage of structure folding and, 
along with L24, is the initiator of the entire process of 
ribosome assembly [24].
A conclusion can be made from the aforementioned 
that PrmB in vivo methylates L3 by binding to the ri-
bosome at one of the intermediate stages of its folding; 
hence, it is likely to have a certain effect on the cor-
rectness of its packing. Thus, the PrmB enzyme can be 
referred to ribosome assembly factors.
Protein L3 has a globular domain located on the ribo-
some surface and a long tail that is deeply submerged 
inside. The modified 150th glutamine residue is located 
inside the ribosome near the tunnel or the growing pol-
ypeptide chain. It forms contacts with the nucleotide 
residues G2032, C2055, and A2572, which are located 
in the 3’-terminal region of 23S rRNA. This residue ap-
parently contributes to the formation and maintenance 
of the correct rRNA conformation.
Methylation of Protein S11 and Formation of the Iso-
meric Peptide Bond
In ribosomal protein S11, the N-terminal amino group 
belonging to the alanine residue undergoes methyla-
tion. In addition to methylation, the formation of an 
isopeptide bond is observed. Only one E. coli protein, 
S11, is susceptible to this transformation. During this 
process, the peptide bond between the first and second 
residues (alanine and lysine) in the S11 molecule is de-
stroyed (Fig. 3) [25].
It was reported [26] that the isoaspartate residue was 
detected in the protein S11; there is 0.5 mol of isoas-
partate per 1 mol of the protein. It was demonstrated 
that only S11 has such a modification in the logarithmic 
growth phase.
Neither the enzymes that perform the aforemen-
tioned modifications nor the functional role of the mod-
ifications have been ascertained.
Protein S11 is located in immediate proximity to 
mRNA and tRNA in the E-site. Its N-terminus pro-
truding on the ribosome surface cannot be seen in the 
crystal structure and probably has no fixed orienta-
tion. It is unlikely that the modified residue contrib-
utes to the maintenance of the ribosome structure. The 
methylated N-terminus of S11 probably interacts with 
tRNA and facilitates its escape from the E-site.
Methylation of Protein L7/L12
Ribosomal protein L7/L12 is monomethylated at the 
Fig. 3. Structure 
of the N-terminal 
amino acid resi-
due of S11, which 
is methylated and 
forms isopeptide 
linkage [25].REVIEWS
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ε-amino group of the 81st lysine residue. The degree of 
methylation strongly depends on temperature. At 37°С, 
almost no modification is observed (less than 0.1 methyl 
groups per protein molecule). The number of groups 
introduced increases abruptly with decreasing temper-
ature and is equal to 0.6 monomethyl-lysine residues 
per protein molecule [27]. The enzyme performing this 
reaction has not been identified.
The protein L7/L12 is located in the ribosome as a 
tetramer representing a rod-shaped appendix, the so-
called “L7/L12 stalk”. Each chain in a tetramer con-
sists of two domains: the N-terminal domain, which 
is bound to protein L10, and the C-terminal domain. 
The domains are connected by a flexible linker, which 
makes it possible for the C-terminal domains to change 
their orientation with respect to the large subunit. 
Thus, L7/L12 is the only ribosomal protein that does 
not have direct contact with rRNA; it is bound to it via 
the complex with protein L10. This complex plays a sig-
nificant role in the translation process; it participates in 
the binding between the translation factors (IF2, EF-
Tu, EF-G, and RF3) and the ribosome [28]. The meth-
ylated residues are located in the C-terminal domain, 
and it is possible that they contribute to the interaction 
with the translation factors.
Methylation of Proteins L16 and L33
N-terminal amino groups are methylated in the ribo-
somal proteins L16 and L33. In L16, the first methio-
nine residue is methylated [29]. In L33, some polypep-
tide chains start with the monomethylated methionine 
(no more than 25%), whereas some chains start with 
monomethylated alanine [30]. Such heterogeneity is 
probably associated with the competition between the 
processes of methylation and N-terminal methionine 
cleavage [30]. The assumption of a possible reduction of 
N-formylmethionine to N-methylmethionine has been 
refuted [3].
The methyltransferases performing the modification 
of proteins L16 and L33 have not been identified.
Another modification type has been detected in pro-
tein L16. Based on the amino acid sequence, the molec-
ular weight of protein L16 is supposed to be 15281.3 Da. 
However, there is no peak in the mass spectrum of this 
protein that would correspond to this weight, although, 
there is a peak corresponding to 15326.2 Da, which is 
higher by 44.9 Da. The methyl group at the N-terminus 
of the protein increases its weight only by 14 Da. This 
entails that the molecule L16 should contain at least 
one more posttranslational modification. Hypotheti-
cally, Arg81 undergoes hydroxylation. However, in 
this case the modified protein should be lighter than 
the value observed by mass spectroscopy: 14.9 Da [1]. 
Another methylation or hydroxylation may take place. 
The more explicit data concerning the nature and lo-
calization of the unknown modification were obtained 
from the mass spectra of the products of tryptic cleav-
age of protein L16.
Proteins L16 and L33 are located near the central 
protuberance on the opposite sides from it. Their N-
terminal residues are exposed to the ribosome surface 
and are not in direct contact with rRNA and the pro-
teins.
ACETYLATION OF RIBOSOMAL PROTEINS
Nα-acetylation  of  proteins  is  catalysed  by  N α-
acetyltransferases, which transfer the acetyl group 
from acetylcoenzyme A to the N-terminal amino group 
of the protein. In eukaryotes, this modification of pro-
teins is widespread: 80–90% of cytoplasmic proteins in 
mammals and 50% in yeasts are acetylated at the N-
terminal amino acid residue [31]. In prokaryotes, this 
modification is rarely realized. Only four E. coli proteins 
are known to undergo this process: the EF-Tu factor 
and the ribosomal proteins S5, S18, and L7. The genes 
which encode the enzymes that perform the modifi-
cation of the ribosomal proteins S5, S18, and L7 were 
determined: rimJ, rimI, and rimL, respectively. Each 
of the mentioned transferases specifically modifies only 
one protein (as opposed to eukaryotes, in which these 
enzymes are less specific). Despite their similar func-
tions, the structures of these enzymes are very differ-
ent. The similarity between sequences RimI (148 resi-
dues), RimJ (194 residues), and RimL (178 residues) is 
19 and 20%, respectively; while that between RimJ and 
RimL is 23% (although RimI and RimJ are alanine acet-
yltransferases, whereas RimL is serine acetyltransfer-
ase). It is likely that these proteins have no common an-
cestor and evolved independently from each other [32].
Eukaryotic Nα-acetyltransferases typically consist 
of two or three different subunits; they cotranslation-
ally modify the substrate, whereas the prokaryotic en-
zymes are most frequently monomeric or in the form of 
homodimers (e.g., RimL) and acetylate substrate post-
translationally [33].
Acetylation of Protein S5
Ribosomal protein S5 is acetylated at the  α-amino 
group of the first alanine residue [34]. The acetylation 
is performed by a specific enzyme, RimJ (ribosomal 
modification) [35]. The rimJ gene encoding this enzyme 
has been identified and sequenced [36].
The substrate specificity of RimJ has been ascer-
tained. Poot et al. [37] investigated an E. coli strain con-
taining the mutation in the central pseudoknot in 16S 
rRNA (C18A). This mutation leads to the disturbance 
of the assembly of the 30S subunit, deterioration of 
binding between it and proteins S1, S2, S18, and S21 28 | ACTA NATURAE |  VOL. 3  № 2 (9)  2011
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and, therefore, to the reduction in translation efficacy. 
Moreover, the mutation results in a decrease in the pro-
portion of acetylated molecules S5; i.e., the activity of 
RimJ decreases. This is apparently connected with the 
fact that S5 is located in immediate proximity to the 
central pseudoknot, in which the mutations can change 
the site of landing of S5 on the 30S subunit; therefore, 
RimJ cannot be bound to the substrate. It should be 
noted that non-acetylated S5 has not been found in the 
assembled 70S mutant ribosomes. The binding between 
the mutant 30S subunit and 50S apparently stabilizes 
the functionally active conformation of the 30S subunit. 
Having this conformation, the 30S subunit becomes the 
RimJ substrate. It was earlier demonstrated that the 
mutation in protein S4 also results in lower efficacy of 
acetylation of S5 [38]. These data attest to the fact that 
acetylation of S5 is performed on an assembled ribo-
some.
The function of RimJ is associated not only with the 
modification of protein S5, but also with other stages 
of biogenesis of the small ribosomal subunit [39]. In the 
E. coli strain with mutation in the gene of protein S5 
(the 28th glycine residue is substituted for aspartic 
acid), the assembly of ribosomes is disturbed, trans-
lation accuracy is reduced, and cold sensitivity is ob-
served. The superexpression of RimJ in this strain 
completely recovers all the translational defects. This 
entails that, regardless of the acetyltransferase actriv-
ity, RimJ contributes to the formation of the correct 
ribosome structure. It can be proven by the fact that 
RimJ is bound to subunit 30S at early stages of its as-
sembly [39]. The functions of RimJ as a factor of ribo-
some and acetyltransferase assembly can be combined 
and performed simultaneously or sequentially.
Protein S5 is located on the side of the small subunit 
that is opposite to the decoding centre. The N-termi-
nal residues protrude over the ribosome surface and 
cannot be seen in the crystal structure. Therefore, the 
α-amino group of the first residue of protein S5 within 
a ribosome is accessible for acetylation, which agrees 
with the results of study [37].
Protein RimJ performs functions that are not di-
rectly connected with the acetylation of S5. It has been 
demonstrated that RimJ is a repressor of the pap oper-
on responsible for pilus biosynthesis in the pathogenic 
E. coli strain causing pyelonephritis. RimJ regulates the 
transcription of this operon depending on environmen-
tal conditions (temperature, the presence of nutrients). 
The mechanism of this regulation and how it is con-
nected to the acetyltransferase function of RimJ have 
not been ascertained [40].
Acetylation of Protein S18
In a similar fashion to S5 and L12, protein S18 under-
goes N-terminal acetylation (at the alanine residue) 
[41]. The modification is performed by the specific 
acetyltransferase encoded by the rimI gene [36].
Acetylation of S18 does not belong to the modifica-
tions that are vital to a cell. The cells with mutations in 
the rimI gene are not only viable, but they also do not 
phenotypically differ from wild-type cells [42].
The 3D structure of RimI from  Salmonella ty-
phimurium (the primary structure being absolutely 
identical to RimI from E. coli) has been determined [32]. 
The enzyme has a mixed αβ-structure, with the cen-
tral seven-stranded β-sheet flanked by four α-helices 
(Fig. 4). The central sheet has a predominately antipar-
allel structure, with the exception of the parallel 4th 
and 5th strands. The order of β-strands in the sheet is 
linear, with the exception of strand β7 that is located 
between β5 and β6. The sheet has a V-shaped struc-
ture, where strands β1–β4 form one shoulder, while 
strands β5–β7 form the other shoulder. It is assumed 
that the acetyltransferase center is located in the V-
shaped broadening between the β4- and β5-strands.
Based on the data on the 3D structure of the com-
plex of enzyme with substrate and coenzyme (acetyl 
coenzyme A), a mechanism of acetyltransferase reac-
tion was proposed (Fig. 5).
The N-terminal nitrogen atom in S18 nucleophili-
cally attacks the carbonyl carbon atom of acetyl co-
Fig. 4. Structure of the RimI-bisubstrate complex. Bisub-
strate is shown as sticks. From the N-terminus, secondary 
structural elements are colored green (b1, a1, a2), yellow 
(b2–b4), red (a3, b5), and blue (a4, b6) [32].REVIEWS
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enzyme A, with the Glu103 residue acting as a proton 
acceptor (Fig. 5a). This results in the formation of a tet-
rahedral intermediate (Fig. 5b). Tyr115 acts as a proton 
donor upon decomposition of the intermediate (Fig. 5c).
Despite the fact that the mechanism of S18 acetyla-
tion has been ascertained, the function of acetylation 
and the stage at which it takes place have not as yet 
been elucidated. Protein S18 is located in the central 
domain of the small ribosomal subunit near proteins 
S11 and S6. The interaction between S18 and S6 is so 
strong that a stable heterodimer is formed [43]. S18 is 
located near the E-site. The first 15 N-terminal resi-
dues in S18 cannot be seen in the crystal structure of 
the ribosome; therefore, it is most likely that they do 
not have a fixed 3D position. They are probably located 
near the site of mRNA landing on the small subunit. In 
this case, the N-terminal acetylation can have an effect 
on the translation initiation process.
Acetylation of Protein L12
Ribosomal protein L12 exists in two different forms: 
the non-acetylated (L12) and acetylated (so-called L7) 
forms [44]. Due to the identity of the amino acid se -
quences, this protein is called L7/L12.
Acetylation of the α-N-atom of Ser1 in protein L12 
is performed by the specific enzyme RimL and results 
in the formation of L7 [45]. RimL is capable of  in vi-
tro acetylation of the two unbound proteins L12 [46] 
and L12 within the ribosome [33]. Apparently,  in vivo 
modification of L12 can also take place at any stage of 
ribosome biogenesis. As opposed to the totally modi-
fied S5 and S18, L12 is only partially acetylated. The 
L7/L12 ratio varies depending on the phase and rate 
of cell growth. In the middle of the logarithmic phase, 
the proportion of L12 attains 85%; then, the L7 content 
gradually increases to 75–80% in the stationary phase 
[47]. When the cells grow in a minimum medium, all of 
the protein is converted into the L7 form.
The modification of L12 was shown to enhance the 
strength of the complex formed by the L7/L12 tetra-
mer and protein L10 [48]. These authors account that 
by the fact that acetylation stabilizes the N-terminal 
α-helices of L7 (are denoted as α1 in Fig. 6) and fix the 
position of the N-terminal residue in space, thus mak-
ing the structure more compact and stronger.
Nevertheless, the strain with a mutation in the rimL 
gene, in which the entire protein L12 is present in 
deacetylated form, has no noticeable phenotypic dis-
tinctions from the wild-type strain. In particular, there 
is no difference in the cell growth rate at 25, 37, or 42°С 
[46]. Therefore, the modification is insignificant for ri-
bosome functioning; the question as to its possible func-
tion remains open.
The substrate specificity of RimL and nature of 
the N-terminal amino acid residue of the substrate 
was studied in [33]. According to the data published, 
in Nα-acetylated proteins these residues typically are 
represented by serine, alanine, or methionine. Thus, it 
is serine for L12 from E. coli and alanine for L12 from 
Pseudomonas aeruginosa and Bacillus subtilis and S18 
and S5 from E. coli. The assumption that RimL is not 
specific towards the N-terminal residue has been ex-
perimentally confirmed. RimL efficiently acetylates 
in vitro the mutant L12, with Ser1 replaced by Ala1 
[33].
In the case of eukaryotic Nα-acetyltransferases, the 
second amino acid residue of the Nα-acetylated protein 
has an effect on the modification of the first protein. 
If the second residue is aspartate or glutamate, modi-
fication occurs efficiently. In order to investigate the 
effect of the second amino acid residue on the activ-
ity of RimL, the mutant L12 was obtained, with Ile2 
replaced by Asp2. It turned out that RimL acetylates 
this mutant protein much less efficiently in comparison 
а  b  c
Fig. 5. The pro-
posed mechanism 
of the reaction 
catalyzed by RimI. 
(i) Nucleophilic at-
tack on the carbo-
nyl carbon of Ac-
CoA; (ii) collapse 
of the tetrahedral 
intermediate; (iii) 
product complex 
[32].30 | ACTA NATURAE |  VOL. 3  № 2 (9)  2011
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with the native L12. This, again, emphasizes the differ-
ence between prokaryotic Nα-acetyltransferases and 
eukaryotic ones [33].
The crystal structure of RimL was obtained from 
Salmonella typhimurium (the similarity between the 
primary structure and the RimL from E. coli is 83%). 
RimL is a homodimer that is capable of binding two 
molecules of acetyl coenzyme A and modifying dimeric 
L12 [49].
METHYLTHIOLATION OF PROTEIN S12
The primary structure of ribosomal protein S12 of 
E. coli was determined chemically; however, its 88th 
amino acid residue could not be identified [50]. The sub-
sequent sequencing of the gene encoding S12 demon-
strated that aspartic acid is located at this position [51].   
Only 20 years later was it shown mass spectrometrical-
ly that the molecular weight of S12 is equal to 13652 Da 
(which is bigger than that predicted on the basis of the 
nucleotide sequence by 46.1 Da) [1].  Further study of 
this phenomenon demonstrated that this discrepancy 
is conditioned by the presence of the methylthioether 
group (–SCH3) (Fig. 7) at the β-carbon atom of Asp88 
[52]. Later, the rimO gene encoding methylthiotrans-
ferase that performs this posttranslational modification 
was found [53].
This reaction is an example of the enzymatic forma-
tion of the C–S bond from C–H, which is relatively rare 
in nature. These reactions occur via a radical mecha-
nism using S-adenosylmethionine as a coenzyme [54]. 
S12 is the conservative element of ribosome; the 
Asp88 residue was found in all known S12 homologues: 
in bacteria, archaebacteria and eukaryotes (although 
the modification is not always observed). Asp88 is lo-
cated near the functional centers of the ribosome. The 
attempts to obtaining E. coli cells with a mutation of 
this amino acid were unsuccessful. All these facts point 
to the significance of Asp88 in the functioning of ribo-
some.
All the methylthiotransferases that had been known 
before RimO posttranscriptionally modify RNA; RimO 
is the first studied enzyme in this family, with a protein 
as its target. In addition to RimO, only one methylthio-
transferase was detected in E. coli: MiaB modifying 
tRNA. The amino acid sequences of these two proteins 
are characterized by a close similarity [53]. In particu-
lar, they both contain the СхххСххС motif, which is 
canonical for the entire methylthiotransferase family.
The methylthiolation of protein S12 was carried out 
via a radical mechanism (Fig. 8). At the first stage, the 
C–S bond in S-adenosylmethionine is broken, yield-
ing an unbound methionine and a 5’-desoxyadenosyl 
radical. Then, this radical takes away a hydrogen atom 
from the β-carbon atom of Asp88. Next, a thioether 
is formed, which undergoes methylation at the final 
stage. Thus, two molecules of S-adenosylmethionine 
are required to modify a single molecule of protein S12 
[55].
At the final stage, the RimO enzyme also takes part 
in the methylation. This means that RimO is methyl-
L10
L10
L7/L12 dNTD
α2   L7/L12 dNTD
L7/L12 CTD
L9
L1
L11
α2
α8
α1
α1
Ac
Ac
Fig. 6. A hypothetical model of E. coli ribosomes with the 
ribosomal stalk complex attached. L10 is shown in blue; 
L7/L12 dimers, in red/magenta and light/dark green. 
The detailed view of the interaction of the L7/L12 NTD 
dimer with a segment of the α8 helix of L10 illustrates the 
hypothesis that N-terminal acetylation results in stronger 
binding of the L7 NTD dimer onto the α8 helix of L10 [48].
S12-aspartate 88
2 SAM  5’-dA + Met
RimO
SAH S12-β-methyl  thio-
aspartate 88
O
H
OH OH
CH3 O
O
O S
H
N H
N
Fig. 7. Reaction catalysed by RimO. The methylthiolation 
of aspartyl 88 of protein S12.REVIEWS
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transferase, although no conservative S-adenosylme-
thionine-binding motifs that are typical of enzymes of 
this class have been detected in it [56].
It was ascertained through spectroscopic studies 
that there are two [4Fe–4S] clusters in the structure 
of RimO (Fig. 9). The first cluster is coordinated by the 
residues Cys150, Cys154, and Cys157 (the conserva-
tive СхххСххС motif); the second is coordinated by 
the residues Cys17, Cys53, and Cys82. It is assumed 
that the first cluster participates in the formation of 
the 5’-desoxyadenosyl radical, whereas the second one 
serves as the source of sulphur atoms for thioether for-
mation [56].
RimO contains the so-called TRAM domain, which 
serves for RNA binding in MiaB [53]. This could be an 
indication that RimO modifies protein S12 within the 
ribosome. It has indeed been confirmed experimentally 
that RimO in vivo methylthiolates residue Asp88 of 
protein S12, which is a component of the small subu-
nit [57]. It was ascertained earlier that the recombinant 
RimO from E. coli and Thermatoga maritima can mod-
ify in vitro the synthetic peptide substrate imitating a 
loop containing residue Asp88; however, the efficacy of 
the modification is very low [58].
It was recently demonstrated that in addition to 
RimO, the conservative protein YcaO also partici -
pates in the modification of protein S12; the function 
of YcaO remained unknown. Knockout of the  ycaO 
gene results in the almost complete suppression of 
the methylthiolating activity of RimO. Moreover, the 
transcriptome analysis of strains with the deletion of 
the rimO and ycaO genes points to the overlapping 
of transcriptional phenotypes, which attests to the 
functional similarity between RimO and YcaO. Pro-
tein YcaO is bound to the small subunit and probably 
functions as a chaperon by facilitating the formation 
of the enzyme–substrate complex [57].
It should be mentioned that after the methylthiola-
tion of the aspartic acid residue, a new chiral centre 
(β-carbon atom) emerges; however, its configuration 
has not yet been ascertained.
Protein S12 consists of a globular domain located 
near the A-site in the decoding centre and a long rod-
shaped tail, which fixates the protein on the small 
subunit. S12 is the only protein located on the contact 
surface between the large and small subunits. The 
modified residue is located near the decoding centre; 
however, it forms direct contacts neither with mRNA 
nor tRNA. It is submerged into a pocket formed by two 
loops: the first loop is formed from the nucleotides 522–
528 of 16S rRNA, the second loop is formed from the 
amino acid residues 44–51 of S12.
The function of S12 modification has not been eluci-
dated yet. It is known that mutations in the neighbor-
ing residues (Lys87, Ley89, Pro90, Gly91, and Arg93) 
lead to the emergence of resistance to streptomycin 
or streptomycin dependence [53]. It is also known that 
protein S12 participates in the spontaneous transloca-
tion of the ribosome (independent of EF-G and GTP), 
whereas the mutation in the neighboring 87th amino 
acid residue violates this function [59]. Nevertheless, in 
case of mutation in the rimO gene, none of these phe-
notypical changes take place. The only difference be-
tween this mutant and the wild-type strain consists in 
a slightly reduced growth rate [53].
MODIFICATION OF PROTEIN S6
Ribosomal protein S6 has a unique type of posttrans-
lational modification. From two to six glutaminic acid 
residues (…ADDAEAGDSEE(E)0–4) are located on its 
C-terminus [60, 61]. Only the first two (…ADDAEAGD-
SEE) are encoded in the gene (rpsF) [62]; the rest of the 
residues are added posttranslationally. The modifica-
tion occurs in a stepwise fashion; glutaminic acid resi-
dues being added one by one [63].
The mutant strain was obtained; it contained only 
two glutaminic acid residues and demonstrated no het-
erogeneity of the C-terminus of protein S6. Using this 
SAM
RimO-[Fe-S]
5’-deoxyadenosyl 
radical
S12-[D88] 5’-deoxyadenosine
«S» SAM
е-
Fig. 8. Mechanism of the reaction catalysed by RimO [55].
Cys
Fe
Fe
Fe
Fe
Cys
Cys
S
S
S
S
Fig. 9. The 
[4Fe-4S] cluster 
coordinated by 
cysteine residues 
in the structure 
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strain, the rimK gene that is responsible for this modi-
fication was detected [64]. This gene encodes an enzyme 
with a molecular weight of 31.5 kDa, which recognizes 
the protein S6 and adds more residues on its C-termi-
nus. In the case of the mutation in the rpsF gene, re-
sulting in substitution of the penultimate residue of 
glutaminic acid by lysine, no posttranslational modifi-
cation of protein S6 was observed [64]. This means that 
RimK recognizes the C-terminal region of wild-type 
protein S6. In some mutant strains, RimK adds more 
than four glutaminic acid residues to S6; however, the 
reasons for this have not been elucidated [65].
It was ascertained that under conditions when ribo-
some assembly does not occur (in cells irradiated with 
ultraviolet light), S6 does not undergo modification [66]. 
The RNA-binding motif was found in RimK using bio-
informatics methods [67]. These data may point to the 
fact that modification occurs during or after the inser-
tion of protein S6 into the ribosome.
Protein S6 is located in the central domain of the 
small ribosomal subunit. By interacting with the pro-
teins S18, S8, and S15, it protects 16S rRNA against 
attacks by endonucleases. The C-terminal amino acid 
residues of S6 protrude outside and are not seen in the 
crystal structure.
S6 is the most acidic protein of the 30S subunit 
(pI = 4.8), the posttranslational modification enhanc-
ing its acidity to a larger extent. The function of this 
modification has yet to be elucidated; however, it is the 
first known case of posttranslational addition of amino 
acid residues. 
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